Evidence map›Paper›PMID 36644435›Full record

ArticleAccess microbiology2022

Prosthetic valve endocarditis due to highly beta-lactam-resistant

Ippei Tanaka, Shinichiro Morioka, Arisa Honda, Ryoichi Miyazaki, Takeaki Wajima, Hidemasa Nakaminami, Tomoyuki Kato

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Access microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Clinical isolates ofAntimicrobial agents and chemotherapy · 2024
    Article
  2. Insights into the role ofFrontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ippei TanakaDepartment of Pharmacy, Japanese Red Cross Musashino Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7867-9381
Shinichiro MoriokaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2042-0195
Arisa HondaDepartment of Pharmacy, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Ryoichi MiyazakiDepartment of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Takeaki WajimaDepartment of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Hidemasa NakaminamiDepartment of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Tomoyuki KatoDepartment of Pharmacy, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Musashino Red Cross Hospital · JPTokyo University of Pharmacy and Life Sciences · JPNational Center for Global Health and Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are limited reports of patients with prosthetic valve infective endocarditis (IE) or recurrent IE due to highly beta-lactam-resistant viridans group streptococci. We present a case in which a patient with native valve IE due to beta-lactam-susceptible

Indexed as

drug resistanceendocarditisheart valve prosthesisStreptococcus oralisvancomycinviridans streptococci

Identifiers

PMID36644435
PMCPMC9833417
OpenAlexW4308102577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.